banner
mattherder.bsky.social
@mattherder.bsky.social
45 followers 48 following 45 posts
law prof
Posts Media Videos Starter Packs
Reposted
Bad to much worse:
www.statnews.com/2025/11/03/g...
When NYT broke news of Tidmarsh's leave, it seemed maybe he was being retaliated against for criticizing commissioner's vouchers. Now it seems he may have used his FDA role for personal vendettas+possible extortion. The civil complaint is shocking.
Lawsuit against top FDA drug regulator is packed with incendiary texts, emails
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts and emails
www.statnews.com
100%
Per the book review @thelancet.com "The story he tells begins in the Hard Rock Hotel bar in Davos, Switzerland, in January, 2020, where discussions laid the foundation for COVAX".🌐💉
However one views COVAX, this origin story is a bit too typical of how & where key global health decisions are made...
Mere minutes away! Join us if you’re in the HRM.
TODAY! "Making the Technical Political: The Long Road to the Pandemic Agreement" w/Roojin Habibi
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
Reposted
This is a fantastic, well-supported 3-year post-doc in our Division of Medical Ethics at Penn. Please share (and apply if interested!)
Thrilled to welcome @roojinhabibi.org to @schulichlaw.bsky.social tomorrow!
TOMORROW! "Making the Technical Political: The Long Road to the Pandemic Agreement" w/Roojin Habibi
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
Great thread, summarizing our work on J&J's Advac and the perils of what we term 'platform thinking'!
New paper!
Karim Sariahmed, Janice E. Graham, Matthew Herder & Christopher J. Morten, Public Sector Innovation and the Constraints of “Platform Thinking”: An Account of Johnson & Johnson’s Viral Vector Vaccines, 387 Social Science & Medicine 118687 (2025).
www.sciencedirect.com/science/arti...
1/
Public sector innovation and the constraints of ‘platform thinking’: An account of Johnson & Johnson's adenoviral vector vaccines
Scholarship on political economy of vaccines in the COVID-19 era has focused on mRNA. Yet Johnson & Johnson's (J&J) vaccine based on recombinant adeno…
www.sciencedirect.com
What he said.

And I hope that #HESA will hear *evidence* on how attempts to throw $$ at #bigpharma or make industry friendly policies have failed to attract a larger industry presence.

Time for some fresh thinking about how to create/sustain a reliable/affordable supply of essential medicines!
Interested to see where Parliament's Standing Committee on Health ( #HESA) goes with this study on "Canada's Pharmaceutical Sovereignty". 🛃💊
A little over 90 minutes from now! @marthapaynter.bsky.social is not to be missed.

Join us.
TODAY! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
Reposted
TOMORROW! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
Reposted
Our FIRST seminar of this academic year - THIS FRIDAY! "Not Lawless at all: Abortion in Canada" w/Martha Paynter
🕛 Time: 12:10 - 1:20 PM
📷 In-Person: Weldon Law Building, Room 104 dal.ca/faculty/law/
@schulichlaw.bsky.social
Pssst....I'm hiring a Research Fellow to work on 'infectious disease innovation governance'. If you have legal training and you're interested in issues of access to medicines & global health, please consider applying.

Details at the link below (Nov. 3 deadline):

dal.peopleadmin.ca/postings/19632
Research Fellow
Working in close collaboration with the Chair in Applied Public Health, the Infectious Disease Innovation Governance (IDIG) Research Fellow will play a leading role in a variety of research and capaci...
dal.peopleadmin.ca
Live in the Halifax area but concerned about global health?

This talk on Thursday featuring @stephanienolen.bsky.social is NOT to be missed!
New paper alert! Led by @hollylynchez.bsky.social we report findings from interviews with reps from @fda.gov, pharma, patient orgs + payers about the challenges involved in securing rigorous safety/efficacy evidence re: drugs granted accelerated approval.

See the thread below for details.
Here's our new article reporting findings from stakeholder interviews in which we hoped to learn what it takes to successfully complete rigorous confirmatory studies after accelerated approval. Instead, we mostly heard willingness to trade rigor for feasibility. 1/
academic.oup.com/healthaffair...
Flexibility Over Rigor: Stakeholder Acceptance of the Limitations of Confirmatory Studies Following Accelerated Approval
Despite the importance of postmarketing requirements (PMRs) following accelerated approval and well-recognized shortcomings in their rigor and timeliness,
academic.oup.com
I’ll answer if you say who you are.
This is a fake account and pure misogyny. I’m at a complete loss.
Reposted
Paul Magennis and Kim Carlson continue to do great work responding to irresponsible journalism spreading myths, mis-, and disinformation about MAiD in Canada.